Immunic Hopes for Trial Results in 2020

June 25, 2020

Immunic Hopes for Trial Results in 2020

Immunic has commenced phase II CALVID-1 clinical trials of their IMU-838 therapy to treat patients with coronavirus. The U.S.-based biotech firm expects trial results later in the year. Yourway has the global capacity to transport sensitive trial materials and deliver trial material directly to patients.

Back to Index

Media

Upcoming Event

Clinical Operations in Oncology Trials East Coast 2020

July 15-16, 2020
Boston, MA, USA (Virtual)

Schedule a Meeting

Media

Articles

SUPPLY CHAIN SOLUTIONS – Storage and Distribution Support for Clinical Trials Worldwide

Open chat

Hello! How can I help you?